Articles with "busulfan cyclophosphamide" as a keyword



Photo from wikipedia

Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma

Sign Up to like & get
recommendations!
Published in 2019 at "Annals of Hematology"

DOI: 10.1007/s00277-019-03667-1

Abstract: Primary central nervous system lymphoma (PCNSL) is a rare extranodal non-Hodgkin lymphoma for which standard treatment has yet to be established. High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is a suitable consolidation strategy… read more here.

Keywords: chemotherapy; busulfan; consolidation; primary central ... See more keywords
Photo from wikipedia

Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial

Sign Up to like & get
recommendations!
Published in 2020 at "Annals of Hematology"

DOI: 10.1007/s00277-020-04312-y

Abstract: Busulfan and cyclophosphamide (BuCy) is a frequently used myeloablative conditioning regimen for allogeneic hematopoietic cell transplantation (allo-HCT). Theoretical considerations and pharmacological data indicate that application of busulfan prior to subsequent cyclophosphamide (BuCy) may trigger liver… read more here.

Keywords: busulfan; regimen allogeneic; allogeneic hematopoietic; conditioning regimen ... See more keywords
Photo from wikipedia

Conditioning regimen with a 75% dose of standard busulfan/cyclophosphamide plus fludarabine before cord blood transplantation in older patients with AML and MDS

Sign Up to like & get
recommendations!
Published in 2019 at "International Journal of Hematology"

DOI: 10.1007/s12185-019-02688-w

Abstract: In this retrospective study, we aimed to establish a conditioning regimen for older patients receiving cord blood transplantation (CBT). This study included 21 older patients [median age 65 (58–73) years] with acute myeloid leukemia and myelodysplastic… read more here.

Keywords: older patients; cord blood; conditioning regimen; blood transplantation ... See more keywords
Photo from wikipedia

Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.

Sign Up to like & get
recommendations!
Published in 2019 at "Hematology/oncology and stem cell therapy"

DOI: 10.1016/j.hemonc.2019.09.002

Abstract: OBJECTIVE/BACKGROUND Busulfan/cyclophosphamide (Bu/Cy) and busulfan/fludarabine (Bu/Flu) are both standard myeloablative conditioning (MAC) regimens for allogeneic hematopoietic cell transplantation (alloHCT). We compared the effectiveness of these regimens with a focus on quality of life (QOL). METHODS… read more here.

Keywords: busulfan; cell; busulfan fludarabine; allogeneic hematopoietic ... See more keywords